AgaMatrix

AgaMatrix is a medical technology company based in Salem, New Hampshire, founded in 2001. The company specializes in designing, developing, and marketing blood glucose monitoring systems and diabetes management solutions. AgaMatrix focuses on creating accurate, affordable, and user-friendly products that help individuals with diabetes and healthcare providers manage the condition effectively. The product lineup includes blood glucose meters, test strips, and connected mobile applications that integrate with cloud platforms for data management. Notably, AgaMatrix is recognized for its WaveSense™ technology, which enhances the accuracy of glucose tests. The company has launched over 17 FDA-cleared blood glucose monitoring products, including the iBGStar, the first FDA-approved smartphone-linked diagnostic device. AgaMatrix also offers continuous glucose monitoring solutions and supports diabetes management through mobile and cloud-based platforms. With a commitment to innovation and quality, AgaMatrix operates a modern facility that houses research and development, engineering labs, and quality assurance testing. The company has established a global presence through partnerships and serves a diverse customer base, including individuals with diabetes, healthcare providers, and pharmacies.

• Employees 93
• Founded 2001
• Annual Revenue $43900000
• Total Funding $166660000